| COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis of current literature MA Raja, MA Mendoza, A Villavicencio, S Anjan, JM Reynolds, ... Transplantation Reviews 35 (1), 100588, 2021 | 223 | 2021 |
| Clinical “real‐world” experience with letermovir for prevention of cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients A Anderson, M Raja, N Vazquez, M Morris, K Komanduri, J Camargo Clinical transplantation 34 (7), e13866, 2020 | 63 | 2020 |
| Clinical presentation and outcomes of COVID‐19 following hematopoietic cell transplantation and cellular therapy JF Camargo, MA Mendoza, R Lin, IV Moroz, AD Anderson, MI Morris, ... Transplant infectious disease 23 (4), e13625, 2021 | 24 | 2021 |
| Retrospective comparative analysis of cardiovascular implantable electronic device infections with and without the use of antibacterial envelopes A Hassoun, ED Thottacherry, M Raja, M Scully, A Azarbal Journal of Hospital Infection 95 (3), 286-291, 2017 | 18 | 2017 |
| Successful treatment of disseminated disease due to highly resistant Aspergillus calidoustus with a novel antifungal therapy JF Camargo, R Jabr, AD Anderson, L Lekakis, M Diaz-Paez, LM Briski, ... Antimicrobial agents and chemotherapy 66 (3), e02206-21, 2022 | 11 | 2022 |
| Progression of human monkeypox infection despite tecovirimat in an immunocompromised adult F Dammann, M Raja, JF Camargo Transplant Infectious Disease 25 (1), e14022, 2023 | 9 | 2023 |
| Is the outcome of SARS-CoV-2 infection in solid organ transplant recipients really similar to that of the general population? MA Mendoza, M Raja, A Villavicencio, S Anjan, Y Natori American Journal of Transplantation 21 (4), 1670-1671, 2021 | 7 | 2021 |
| Breakthrough invasive fungal infections on isavuconazole prophylaxis in hematologic malignancy & hematopoietic stem cell transplant patients AM Khatri, Y Natori, A Anderson, R Jabr, SA Shah, A Natori, ... Transplant infectious disease 25, e14162, 2023 | 6 | 2023 |
| Emergence of maribavir resistance after CMV treatment in hematopoietic stem cell transplant recipient J Bini Viotti, F Dammann, AM Jimenez Jimenez, AD Anderson, MI Morris, ... Annals of hematology 102 (8), 2283-2284, 2023 | 6 | 2023 |
| Incidence and outcomes of cytomegalovirus reactivation after chimeric antigen receptor T-cell therapy RY Lin, AD Anderson, Y Natori, M Raja, MI Morris, AJ Jimenez, ... Blood Advances 8 (14), 3813-3822, 2024 | 4 | 2024 |
| Early administration of SARS‐CoV‐2 monoclonal antibody reduces the risk of mortality in hematologic malignancy and hematopoietic cell transplant patients with COVID‐19 R Jabr, A Khatri, AD Anderson, LC Garcia, JB Viotti, Y Natori, M Raja, ... Transplant infectious disease 25 (1), e14006, 2023 | 4 | 2023 |
| Shewanella cellulitis and bacteremia following marine water exposure M Raja, JAG Zamora, I Roig IDCases 12, 140, 2018 | 4 | 2018 |
| Successful restoration of protective immunity against measles, mumps, and rubella following MMR vaccination in adult hematopoietic cell transplant recipients RY Lin, AD Anderson, MI Morris, M Raja, KV Komanduri, JF Camargo Transplant infectious disease 25 (2), e14043, 2023 | 3 | 2023 |
| Adverse events after SARS‐CoV‐2 vaccination in solid organ transplant recipients: A systematic review A Villavicencio, Y Ebisu, M Raja, AP Sanchez‐Covarrubias, JM Reynolds, ... Transplant infectious disease, e13936, 2022 | 3 | 2022 |
| Difference between SARS‐CoV‐2, seasonal coronavirus, influenza, and respiratory syncytial virus infection in solid organ transplant recipients MA Mendoza, G Motoa, MA Raja, P Frattaroli, A Fernandez, S Anjan, ... Transplant infectious disease 25 (1), e13998, 2023 | 2 | 2023 |
| Hepatitis flare in hepatitis B core antibody positive kidney recipients treated with rituximab. M Raja, Y Natori, C Donato-Santana, D De Lima, A Centeno, A Mattiazzi, ... Transplant Infectious Disease 22 (1), 2020 | 2 | 2020 |
| Solitary brain mass in a patient with seizures: An unexpected infectious etiology M Raja, JAG Zamora, A Hassoun Diseases 6 (3), 54, 2018 | 2 | 2018 |
| Visceral leishmaniasis with cutaneous involvement caused by Leishmania infantum-chagasi M Raja, JAG Zamora IDCases 11, 16, 2017 | 2 | 2017 |
| 2709. Breakthrough fungal infection after isavuconazole primary prophylaxis in patients with hematologic malignancy and hematopoietic stem cell transplant: Systematic Review K Ishida, M Haraguchi, M Kimura, H Araoka, JM Reynolds, M Raja, ... Open forum infectious diseases 10 (Supplement_2), ofad500. 2320, 2023 | 1 | 2023 |
| 2120. Respiratory Viral Infections in Patients with Hematologic Malignancies JL Cardenas, M Raja, JF Camargo, MI Morris, Y Natori Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 1741, 2022 | 1 | 2022 |
